Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM: FIRST trial subanalysis of Canadian/US patients

TY - JOUR

T1 - Continuous lenalidomide and low-dose dexamethasone in patients with transplant-ineligible newly diagnosed MM

T2 - FIRST trial subanalysis of Canadian/US patients

N1 - Publisher Copyright: © 2020 The Authors. Cancer Medicine published by John Wiley & Sons Ltd.

PY - 2020/12

Y1 - 2020/12

KW - Canada

KW - United States

KW - lenalidomide

KW - newly diagnosed multiple myeloma

KW - transplant-ineligible

UR - http://www.scopus.com/inward/record.url?scp=85092348514&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85092348514&partnerID=8YFLogxK

U2 - 10.1002/cam4.3511

DO - 10.1002/cam4.3511

M3 - Article

C2 - 33049118

AN - SCOPUS:85092348514

SN - 2045-7634

VL - 9

SP - 8923

EP - 8930

JO - Cancer Medicine

JF - Cancer Medicine

IS - 23

ER -